Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Amgen

The drug company that prospered without creating any drugs

The new drug looked so promising — except for that one warning sign.

Tribune News Service

How Horizon Therapeutics sold to Amgen for $27.8 billion without ever licensing a drug of its own

Horizon grew large by snapping up cheap drugs from other companies, marketing them to perfection, and jacking up prices.

Fortune

Red-Hot Obesity-Drug Maker Novo Nordisk Soars To Record On A $2.7 Billion Deal

Novo Nordisk stock popped Wednesday after the drugmaker inked a $2.7 billion deal that bolsters its diabetes and obesity treatments.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

Novo Hits Another Record High As WHO Considers A Key Move In Obesity

The World Health Organization will consider adding obesity treatments to its "essential medicines list." The move could help some drug stocks.

Investors Business Daily

3 High-Quality Stocks to Add to Your Watchlist Now

Despite the bank failures, the Fed will likely keep raising interest rates to bring inflation down. This is expected to keep the stock market under pressure. Amid this backdrop, it could be wise for investors to add high-quality stocks Visa (V), Amgen (AMGN), and Box (BOX) to their watchlist. Keep…

StockNews.com

3 Dow Stocks to Buy More of in March 2023

With the Fed keen on further interest rate hikes this year, the stock market will likely remain under pressure. Amid this backdrop, it could be wise for investors to buy fundamentally strong Dow stocks like Verizon Communications (VZ), Amgen (AMGN), and International Business Machines (IBM). Read more….

StockNews.com

Dow Jones Battles Key Support As Indexes Trade Near Session Lows; Sellers Hit Chevron, Salesforce

The Dow Jones held up better than the Nasdaq composite midday Friday, helped by strong showings from Amgen, Merck and Coca-Cola.

Investors Business Daily

Read news from The Economist, FT, and more,
with one subscription

AbbVie's Humira: The Downfall Won't Be As 'Draconian' As Initially Expected

AbbVie stock won at least one upgrade Friday after issuing long-awaited guidance for Humira for the first year it faces new competition.

Investors Business Daily

How To Profit From Amgen Stock's Plunge Using Options

Amgen (AMGN) stock has had a difficult few weeks, with the stock dropping from 295 to 240. It is currently the most oversold stock in the Dow Jones Industrial Average. When a quality company has a big drop like this, I like to use a strategy called a diagonal put…

Investors Business Daily

Market Rally Powers Higher On Tame Fed, Meta Earnings; Apple, Google, Amazon In Focus: Weekly Review

The market rally had powerful gains on a relatively tame Federal Reserve and a booming Meta stock, shrugging off many weak earnings reports.

Investors Business Daily

There's A Key Element Missing From Amgen's 2023 Outlook, Making Comparisons 'Messy'

Amgen issued an outlook that discounts its looming acquisition of Horizon Therapeutics. In response, Amgen stock skidded Wednesday morning.

Investors Business Daily

AbbVie's Two-Decade Humira Monopoly Ends With Amgen's 55% Discounted Knockoff

AbbVie's two-decade Humira monopoly came to an end Tuesday after Amgen launched its biosimilar copy. But AbbVie stock advanced.

Investors Business Daily

Dow Jones Falls 225 Points After Jobless Claims; Netflix Earnings Due

The Dow Jones Industrial Average fell 225 points Thursday after first-time jobless claims. Netflix earnings are due out after the market close.

Investors Business Daily

Dow Jones Rises After Cool Inflation Report, Weak Retail Sales; Tesla Extends Gains

The Dow Jones Industrial Average rose Wednesday on a cool inflation report and weak retail sales. Tesla stock raced higher, looking to add to Tuesday's surge.

Investors Business Daily

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Dow Jones Drops After Weak Manufacturing Data; Goldman Sachs Slides On Earnings Miss

The Dow Jones dropped Tuesday ahead of more key inflation data due out Wednesday. Goldman Sachs fell on an earnings miss.

Tribune News Service

Obesity treatments catch drugmakers’ eyes as sales seen soaring

Three years ago, drugmakers and laboratories around the world responded to the pandemic with Covid-19 vaccines. Now that the urgency has faded, they’re collectively turning attention to an older pandemic: obesity.

Investors Business Daily

Genetics, Alzheimer's And AI — Why 2023 Could Be The Year For Biotech Stocks

If there's one biotech area to watch in 2023, it's genetic medicine, like CRISPR. But other trends also point to a big year for biotech stocks.

Investors Business Daily

'Dogs Of The Dow' Stocks Just Paid Off; Here Are The Top 10 For 2023

Owning the "Dogs Of The Dow" stocks paid off in 2022. And they could be even more lucrative this year.

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

IBD Stock Of The Day: How These Issues In 2023 Could Spark, Or Slam, Eli Lilly Stock

Eli Lilly is the IBD Stock Of The Day as the company explores new methods of treating Alzheimer's and obesity, driving LLY stock near highs.

Investors Business Daily

Dow Jones Reverses Lower Amid Economic Data; Tesla Dives On Deliveries Miss

The Dow Jones Industrial Average reversed lower Tuesday amid economic data. Tesla stock dived after reporting record deliveries that missed estimates.

Investors Business Daily

Dow Jones Falls 275 Points In Final Trading Day

The Dow Jones fell 275 points Friday in the final session of 2022. Tesla stock is set to finish with its worst yearly performance on record.

Investors Business Daily

Dow Jones Rallies 300 Points After Jobless Claims; Tesla Stock Surges On Reiterated Buy Rating

The Dow Jones rallied Thursday after first-time jobless claims. Tesla stock raced higher on a reiterated overweight rating.

Investors Business Daily

The Battles Brewing That Could Stoke Already Red-Hot Eli Lilly Stock

Investors are closely watching two Eli Lilly battles that will unfold in 2023 as LLY stock continues a fevered streak, tacking on new highs.

Investors Business Daily

Dow Jones Rises After Weak Housing Data; Tesla Stock Hits New Low Amid Historic Plunge

The Dow Jones rose Wednesday after key economic data. Tesla stock hit a new low, threatening to add to December's historic plunge.

Investors Business Daily

Dow Jones Falls After Housing Data As Apple Hits New Low; Tesla Plunges On Reduced Production Schedule In China

The Dow Jones Industrial Average turned lower after economic data. Tesla dived on a report that the EV giant will run a reduced production schedule at its Shanghai plant in January.

1 … 8 9 10 11

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations